echo does not require parentheses.Member Portal

LSO's Road Trip Around the Province

SeptemberSep 26 2022 - SeptemberSep 30 2022

  • hours

    • hours
    • days
    • weeks


LSO's Road Trip - Image - Copy

LSO's 3rd Annual


Virtual Road Trip Across The Province


Join the LSO team for our virtual road trip across the province. Each session will explore 5 specific ecosystems in Ontario to find out what the Life Sciences sector looks like in their region, what makes their region unique, and what resources are available.


All presentations for each day will be from 9:00am - 9:30am.


•    Monday, September 26 – Windsor
•    Tuesday, September 27 – Brampton
•    Wednesday, September 28 – London
•    Thursday, September 29 – Simcoe County, Barrie and Orillia
•    Friday, September 30 – Ottawa


Sponsored by:

FSD Pharma Inc

FSD Pharma Inc. is a biotechnology company with three drug candidates in different stages of development. FSD BioSciences, Inc. (“FSD BioSciences”), is focused on pharmaceutical research and development of its lead compound, ultra-micronized palmitoyl ethylamine (“PEA”) or FSD-PEA (formerly called FSD-201). Lucid Psycheceuticals Inc. (“Lucid”), a wholly-owned subsidiary, is focused on the research and development of its lead compounds, Lucid-PSYCH (formerly Lucid-201) and Lucid-MS (formerly Lucid-21-302). Lucid PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. Click here for more details.


City of Brampton

DYK all the new and exciting activities in Brampton in health and life sciences – from venture zones, to new companies, to the Innovation District?  Stakeholders from the City of Brampton will be there to give a quick tour and update on recent and future activities in life sciences. Read about Brampton's Sector Profile


Nordic Pharma Inc

Nordic Pharma is a privately owned, medium-size, fully integrated Pharma company with a history of internal product development and acquisitions. We have established deep roots throughout Europe, and more recently, expanded outside of Europe, with two new affiliates with offices in North America and in Japan.

Nordic Pharma focuses on the development and commercialization of specialty products, which include, but are not limited to, niche hospital and orphan products, to address unmet medical needs. Today, Nordic Pharma has a range of highly specialized proprietary and in-licensed products in the following therapeutic areas: Rheumatology, Sexual and Reproductive Health, and Critical Care.



About Windsor:

Windsor's life science and health care sector is an emerging cluster of strength in research and innovation, specialising in fields such as cancer research, neuroscience/mental health, disparities of health/healthy living, device and drug development. With a highly-skilled manufacturing workforce, Windsor is home to over 50 companies in the sector. This includes a number of major pharmaceutical and gelcap manufacturing companies such as Jamieson Laboratories, CapsCanada, and Catalent - to name a few.

The Windsor region houses the University of Windsor and St Clair College, as well as a number of hospitals with growing health research interests. The collective research and innovation efforts of these institutions is anchored by WE-SPARK Health Institute, a forward-thinking research partnership that brings together health research stakeholders from across the region. Innovation in the region is also supported by Invest Windsor Essex, WEtech Alliance, MedHealth and a unique cross border corridor. Synergizing with the rapid growth in health research capacity, the Windsor-Essex region anticipates momentous opportunities for the broader sector in the near future with the build of a new cutting-edge hospital system and accompanying Health Innovation Park.


About Brampton:

DYK all the new and exciting activities in Brampton in health and life sciences – from venture zones to new companies, to the Innovation District.  Stakeholders from the City of Brampton will be there to give a quick tour and update on recent and future activities in life sciences.

Read about Brampton's Sector Profile


About London:

London, Ontario is a regional healthcare center with many Life Science strengths built on a foundation of highly regarded academic and clinical research capabilities, supported by two large research facilities, two large teaching hospitals, CROs, and an innovative private sector.


About Simcoe County, Barrie and Orillia

Leaders in community health, medical device manufacturers, and emerging industries are driving growth in the life sciences and med-tech sectors in Simcoe County, Barrie, and Orillia. The region’s life sciences sector is anchored by the Royal Victoria Regional Health Centre (RVH) and is home to the headquarters of national and international med-tech innovators. The area is also home to leading education programs developed to fuel growth in this sector, including applied, graduate, post-graduate, and professional development programs offered at Georgian College and Lakehead University,  along with RVH’s partnerships with the University of Toronto and York University. This well-developed network of advanced manufacturers, academic institutions, dedicated government stakeholders, and business innovation services is crucial to growing the regional sector and driving new innovations.

Access to the region’s strategic transportation network allows products and supplies to be shipped to and from the area with ease. Additionally, clients, customers, and the workforce can navigate to, from, and throughout the region easily and conveniently. Surrounded by Georgian Bay, Lake Couchiching, and Lake Simcoe, the area also offers convenient and fun livability and is only a short drive from both the Greater Toronto Area and the cottage country.


About Ottawa:

Ottawa is home to two universities (Carleton University and the University of Ottawa), two colleges (Algonquin College and College La Cité), the National Research Council Canada, six research hospitals, and more than 130 companies. Invest Ottawa helps to grow and build businesses in the region. The Technology Access Centre in Bio-Innovation (TAC-B) at College La Cité is one of 60 TACs across the country that support commercial innovation. Besides industrial and agricultural biotechnology, the TAC-B supports innovation in health biotechnology through collaborative research projects. We look forward to describing the Life Sciences landscape in Ottawa, explaining how the TAC-B supports biotechnology companies (with specialized grants and while keeping none of the IP), even outside Ottawa, and hearing from a few of our industrial partners. The speakers will include Kim Ryell (Invest Ottawa), Ken Lawless (University of Ottawa), Michelle Bamji-Mirza (College La Cite – TAC-B), Stephen Hanson (Spiderwort), and Thinh Nguyen (Gene RxN).

Event expired

Event is in progress

Import to Google Calendar